Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment
Guardado en:
Autores principales: | Hong Chen, Padmanee Sharma, James P Allison, Sumit K Subudhi, Sonali Jindal, Sreyashi Basu, Bilal A Siddiqui, Paul G Corn, Ana M Aparicio, Shalini S Yadav, Rebecca S S Tidwell, Ashwin Varma, Christopher J Logothetis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3455e645104b4f06bbce9f5a72ca3948 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability
por: Diana Russo, et al.
Publicado: (2021) -
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
por: Lewis Zhichang Shi, et al.
Publicado: (2016) -
Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.
por: W Joost Lesterhuis, et al.
Publicado: (2013) -
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer
por: Clélia Coutzac, et al.
Publicado: (2020) -
MINOR SUBSETS OF T-HELPER CELLS (Th THYMIC NAIVE, Th CENTRAL NAIVE, Th9, Th22 AND CD4+CD8+ DOUBLE POSITIVE T-CELLS)
por: S. V. Khaidukov
Publicado: (2014)